Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4/A

PharmaCyte Biotech, Inc.

PMCBNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Jul 17, 2026Accepted Jul 17, 2026, 5:00 PM EDTFiling CIK 1157075Accession 0001683168-26-005621
Share

Structured filing — 4/A

ownership.xml

Open full document ↗

Amendment · This filing reports the amendment as submitted.

Filing details

Report period
2026-03-31
Original submission
2026-04-02
Issuer
PharmaCyte Biotech, Inc.
Issuer CIK
0001157075
Trading symbol
PMCB

Reporting owner 1

Name
Abecassis Michael M
Reporting owner CIK
0001879281
Relationship
Director
Address
C/O PHARMACYTE BIOTECH, INC., 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS, NV, 89169

Derivative transactions

Derivative transactions · 1 reported row
SecurityConversion / exercise price (USD)Transaction dateCodeAmountA / DPrice (USD)ExercisableExpiresUnderlying securityUnderlying sharesOwned afterOwnership
Stock Option (Right to Buy)[F1][F1]2026-03-31[F1]J · Form 4[F1]0[F1]A[F1][F1][F1]Common Stock[F1][F1]0[F1]D
Table key
J · Form 4
Other acquisition or disposition; see explanation
A
Acquired
D
Direct

Footnotes

F1
The reported grant was made in error and has been cancelled.↩ 1↩ 2↩ 3↩ 4↩ 5↩ 6↩ 7↩ 8↩ 9↩ 10↩ 11

Signature 1

Signed
/s/ Michael M. Abecassis
Date
2026-07-17

Company context

Current securities

Historical securities (4)

Recent company filings

  1. Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of AssetsNov 19, 2026
  2. Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other EventsNov 13, 2026
  3. Changes in Registrant's Certifying AccountantOct 16, 2026
  4. 10-Q filingSep 14, 2026
  5. 10-K filingJul 29, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.